EMD-48671

Single-particle
2.2 Å
EMD-48671
3D View Gallery
Deposition: 16/01/2025
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48671

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9mvu summary report (pdf.gz) Map-9mvu FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

C6 Herpes Virus Simplex Neutralizing Nanobody Bound to HSV Glycoprotein gB

EMD-48671

Single-particle
2.2 Å
EMD-48671
3D View Gallery
Deposition: 16/01/2025
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Human herpesvirus 1 (strain 17)
Sample: One C6 Neutralizing Nanobody bound to each monomer of the HSV Glycoprotein B Trimer
Fitted models: 9mvu

Deposition Authors: Viadiu H, Abernathy E, Lee CV, Hung M, Yu Y, Xing W, Yu X
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease.
Lee CV, Viadiu H, Kalamkar A, Bernstein DI, Pae A , Yu X, Wong S, Bravo FJ, Ding S, Seto E, Hung M, Yu Y, Xing W, Papalia GA, Kan W, Carr B, Thomas M, Tong L, Desai P, Jarrousse N, Mercier A, Holdorf MM, Fletcher SP, Abernathy E
(2025) Cell Rep , 44 , 116063 - 116063
PUBMED: 40716063
DOI: doi:10.1016/j.celrep.2025.116063
ISSN: 2211-1247
Grant Support: